Alessandra Bearz

17PUBLICATIONS
75CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyLiquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 08, 2026
Lorlatinib in patients with ALK-positive metastatic NSCLC previously treated with an ALK inhibitor: results from a phase IV study.

Alessandra Bearz, Serena Ricciardi, Nirmal Vivek Raut

|Sep 09, 2025
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B).

James Chih-Hsin Yang, Mengzhao Wang, Ludovic Doucet

|May 14, 2025
Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New Strategies.

Brigida Stanzione, Alessandro Del Conte, Elisa Bertoli

|Jan 25, 2025
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches.

Lorenzo Foffano, Elisa Bertoli, Martina Bortolot

|Jan 25, 2025
Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer.

Sara Torresan, Martina Bortolot, Elisa De Carlo

Pageof 3